Tigecycline treatment in a liver transplant infant with carbapenem-resistant Escherichia coli infection: Case report

INTRODUCTION: During the past decade, the rate of carbapenem resistance among Enterobacteriaceae, mostly in Escherichia coli and Klebsiella pneumoniae, has significantly increased worldwide. It is a great challenge for the choice of drug treatment especially in children. Tigecycline is the first dru...

Descripción completa

Detalles Bibliográficos
Autores principales: Yang, Mei, Gao, Hengmiao, Wang, Xiaoling, Qian, Suyun
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Wolters Kluwer Health 2019
Materias:
6200
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6775363/
https://www.ncbi.nlm.nih.gov/pubmed/31574872
http://dx.doi.org/10.1097/MD.0000000000017339

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6775363/
https://www.ncbi.nlm.nih.gov/pubmed/31574872
http://dx.doi.org/10.1097/MD.0000000000017339

Ejemplares similares